Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem

• Natalia G. Vallianou,
• Gerasimos Socrates Christodoulatos,
• Dimitris Kounatidis,
• Maria Dalamaga

Affiliations

Natalia G. Vallianou

First Department of Internal Medicine, Evangelismos General Hospital, 45-47 Ipsilantou Str, 10676, Athens, Greece

Gerasimos Socrates Christodoulatos

Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Str, Goudi, 11527, Athens, Greece

Dimitris Kounatidis

First Department of Internal Medicine, Evangelismos General Hospital, 45-47 Ipsilantou Str, 10676, Athens, Greece

Maria Dalamaga

Corresponding author. Biological Chemistry-Clinical Biochemistry, National and Kapodistrian University of Athens, Medical School, Mikras Asias #27, Goudi, 11527, Athens, Greece.; Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Str, Goudi, 11527, Athens, Greece